Literature DB >> 9194223

The role of granzyme B cluster proteases in cell-mediated cytotoxicity.

C T Pham1, T J Ley.   

Abstract

Granzymes are neutral serine proteases that are stored in the specialized lytic granules of cytotoxic lymphocytes. A mutation introduced into the granzyme B locus leads to a severe defect in the ability of cytotoxic lymphocytes to induce apoptosis in susceptible target cells, and reduces the severity of class I-dependent acute graft-versus-host disease (GvHD). However, granzyme B-independent cytotoxicity also exists: in CD8+ cells, most of it is perforin-dependent, but in CD4+ cells, the Fas system and an additional pathway are involved. The identification of these pathways and their physiological relevance may lead to new approaches for inhibiting cytotoxic lymphocyte functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194223     DOI: 10.1006/smim.1997.0060

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  10 in total

Review 1.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.

Authors:  A Müllbacher; P Waring; R Tha Hla; T Tran; S Chin; T Stehle; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.

Authors:  K R Jerome; J F Tait; D M Koelle; L Corey
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.

Authors:  Felipe Andrade; Livia A Casciola-Rosen; Antony Rosen
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

5.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

6.  Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.

Authors:  M Merger; J L Viney; R Borojevic; D Steele-Norwood; P Zhou; D A Clark; R Riddell; R Maric; E R Podack; K Croitoru
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

7.  A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.

Authors:  Ali Azizi; Susan Aucoin; Helina Tadesse; Rita Frost; Masoud Ghorbani; Catalina Soare; Turaya Naas; Francisco Diaz-Mitoma
Journal:  Genet Vaccines Ther       Date:  2005-08-22

8.  Proteome Analysis Reveals Distinct Mitochondrial Functions Linked to Interferon Response Patterns in Activated CD4+ and CD8+ T Cells.

Authors:  Marlene C Gerner; Laura Niederstaetter; Liesa Ziegler; Andrea Bileck; Astrid Slany; Lukas Janker; Ralf L J Schmidt; Christopher Gerner; Giorgia Del Favero; Klaus G Schmetterer
Journal:  Front Pharmacol       Date:  2019-07-10       Impact factor: 5.810

9.  Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.

Authors:  Poyee Lau; Guanxiong Zhang; Shuang Zhao; Long Liang; Hailun Zhang; Guowei Zhou; Mien-Chie Hung; Xiang Chen; Hong Liu
Journal:  Cell Mol Immunol       Date:  2022-09-01       Impact factor: 22.096

10.  The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Authors:  Kimberly Shafer-Weaver; Thomas Sayers; Susan Strobl; Eric Derby; Tracy Ulderich; Michael Baseler; Anatoli Malyguine
Journal:  J Transl Med       Date:  2003-12-29       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.